Last reviewed · How we verify
NCT04116814: IRIR
High Resolution Imaging of Retinal Vessels as a Biomarker of Cardiovascular Disease in Patients With Renal Insufficiency - RI
trial testing wall-to-lumen ratio measurement in Retinal Imaging in 83 participants. Status unknown.
29 March 2022
Quick facts
| Lead sponsor | Ramsay Générale de Santé |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 83 |
| Start date | 21 April 2018 |
| Primary completion | 29 March 2022 |
| Estimated completion | 31 March 2022 |
| Sites | 1 location across France |
Drugs / interventions tested
- wall-to-lumen ratio measurement
Conditions studied
- Retinal Imaging — all drugs for Retinal Imaging →
- Cardiovascular Biomarker — all drugs for Cardiovascular Biomarker →
- Renal Insufficiency — all drugs for Renal Insufficiency →
Sponsor
Ramsay Générale de Santé — full company profile →
Who can join
18 and older, any sex, with Retinal Imaging or Cardiovascular Biomarker. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The objectives are to better understand, in the dialysis patient, the relationships between microvascular morphometry and cardiovascular events, survival, arterial hypertension, the pathology responsible for renal failure, the age of dialysis and metabolic parameters. The investigator team also want to better understand the relationship between the diameter of small arteries and parameters such as hypertension, the pathology that causes kidney failure, the age of dialysis, the use of VKA or EPO, metabolic parameters (HbA1c, NFS, reticulocytes, BNP, lipid balance, phosphocalcic balance).
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04116814
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Ramsay Générale de Santé trials
Trials by the same sponsor.
- NCT07353060 — Prognostic Profile of Dupuytren's Disease: a Cohort Study (PRODUCT) · NA · not yet recruiting
- NCT07245823 — Randomized Study Evaluating the Treatment of Vulvovaginal Gaping by Plication of the Puborectalis Muscles Versus Perineo · NA · recruiting
- NCT07142330 — Evaluation of Atherectomy in the Management of Occlusive Lesions of the Common Femoral Arteries · not yet recruiting
- NCT07203131 — Evaluation of the Impact of an Alteration of NAD+ Metabolism on the Renal Prognosis of Patients Admitted to Intensive Ca · NA · recruiting
- NCT07469007 — Impact of Surgery for Deep Posterior Endometriosis on Ovarian Reserve (ENDORO) · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04116814 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Ramsay Générale de Santé
- Last refreshed: 10 October 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04116814.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing